Adherium’s appearance in The Australian and Stockhead’s Investor Guide

30 Sep 2022 | Investors

Adherium has been included in The Australian and Stockhead’sInvestor Guide: Health and Biotech FY23’.

We thank both publications for this opportunity to share the company profile and investor highlights.

The Australian - Stockhead Investor Guide Health and Biotech 2022.pdf